Congress Report Says FDA Broke Protocols In Approval Of Biogen Alzheimer's Drug : vimarsana.com

WESTON (dpa-AFX) - The US Food and Drug Administration's approval process for Biogen's controversial Alzheimer's drug Aduhelm was 'rife with irregularities,' a congressional report said.Oversight

Related Keywords

, Carolyn Maloney , Frank Pallone Jr , Reform Committee , Commerce Committee , Drug Administration , Central Nervous System Drugs Advisory Committee , Reform Committee Chairwoman Carolyn Maloney , Commerce Committee Chairman Frank Pallone , Chairman Pallone , Central Nervous System Drugs Advisory , Congress , Eport , Ays , Roke , Rotocols , Pproval , Iogen , Lzheimer , Rug ,